|
| Commodity | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 |
| Penicillins & their derivs. with a penicillanic acid structure; salts there ... | $18,582,956 | $19,985,753 | $25,679,536 | $25,537,970 | $19,939,795 | $22,812,432 | $19,285,122 |
| Streptomycins & their derivs.; salts thereof | $1,023,954 | $1,370,739 | $1,119,037 | $1,680,303 | $1,859,686 | $1,940,226 | $1,812,255 |
| Tetracyclines & their derivs.; salts thereof | $23,535,407 | $15,494,811 | $17,126,038 | $15,376,511 | $18,459,472 | $13,027,933 | $19,770,938 |
| Chloramphenicol & its derivs.; salts thereof | $2,123,553 | $4,025,373 | $3,030,002 | $3,445,490 | $2,625,389 | $2,736,924 | $2,583,880 |
| Erythromycin & its derivs.; salts thereof | $152,418,196 | $169,519,097 | $168,540,316 | $159,066,596 | $150,613,185 | $183,732,033 | $201,032,220 |
| Antibiotics & their derivs. (excl. of 2941.10-2941.50); salts thereof | $402,404,226 | $400,385,558 | $286,664,506 | $388,429,693 | $431,919,063 | $438,668,613 | $409,508,104 |
| Total | $600,088,292 | $610,781,331 | $502,159,435 | $593,536,563 | $625,416,590 | $662,918,161 | $653,992,519 |
|
|
